Among these genes, mutations in TP53, CDKN2A, PTEN, KEAP1, NF1,RELN, KRAS, and CDH10 have been reported in NSCLC in previous studies [14–16]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.